Drug Resistance
A new oral antibiotic called zoliflodacin has shown effectiveness in treating gonorrhoea, clearing 91 percent of infections in a clinical trial. The drug offers a potential alternative to the increasingly resistant standard treatment of ceftriaxone. With resistance to existing antibiotics rising globally, this development could help delay the emergence of untreatable strains.
Raportoinut AI
India reports 25.5 million TB cases in 2025, with experts warning that irregular treatment fosters drug-resistant strains. Skipping doses allows bacteria to survive, leading to longer, harsher therapies and heightened contagion risks. Proper adherence is crucial for full recovery and public health.